Paulson Richard A. sold KPTI
March 2, 2026 · Form 4 insider transaction
Paulson Richard A. sold 12,361 shares of Karyopharm Therapeutics Inc. at $9.41 per share, a transaction worth $116.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
12,361
Price
$9.41
Total value
$116.3K
InsiderPaulson Richard A.
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 2, 2026
Filing dateMarch 3, 2026
Shares owned after267,030
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.